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Abstract
Trends in the Rate of Inpatient Pediatric Bipolar Disorder Diagnosis between
1996 and 2015
by
Samantha Sherwood
Dr. Andrew Freeman, Committee Chair
Assistant Professor of Psychology
University of Nevada, Las Vegas
The rate of PBD in the U.S. increased dramatically between the mid-1990s and mid-2000s
resulting in concern regarding the potential for misdiagnosis of PBD. However, given that the
rate of PBD diagnosis had not been examined in the U.S. since 2004, the longitudinal trajectory
of PBD diagnosis subsequent to the mid-2000s was unclear. Therefore, the present study utilized
two datasets of administrative billing claims to assess whether longitudinal changes in the rate of
inpatient PBD diagnosis continued to occur subsequent to 2004. Study 1 utilized a nationally
representative dataset of inpatient psychiatric hospitalizations between 1996 and 2010. Deidentified data were obtained from the National Hospital Discharge Survey (NHDS) conducted
annually by the National Center for Health Statistics. Study 2 utilized a state-level database of
de-identified Medicaid billing claims between 2005 and 2015. Data included youth ages five to
17 hospitalized at one of five psychiatric inpatient hospitals in Nevada during the study period.
Results indicated that the proportion of PBD diagnoses to all psychiatric diagnoses increased
between 1996 and 2004 among children and adolescents. The proportion of PBD diagnoses then
decreased between 2004 and 2010 among children but continued to increase for adolescents.
However, the population-adjusted rates of PBD diagnosis per 10,000 individuals in the general
population initially increased until the mid-2000s and then decreased until 2010 for all age
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groups. State-level data indicated a decline in the rate of PBD diagnosis between 2005 and 2015.
Findings provide insight into changing trends in inpatient service utilization for BD in the U.S.
Awareness of the current diagnostic trends for BD may assist inpatient administrators and
clinicians in preparing for anticipated service utilization and planning allocation of resources.
Further research is necessary to evaluate continuously changing diagnostic rates and to determine
the exact causes of changing trends in diagnosis across time.
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Chapter 1: Literature Review
Bipolar disorder (BD) is a severe and chronic illness marked by episodic changes in
mood. BD is among the leading causes of disability worldwide because it is associated with a
high rate of impairment (Lopez & Murray, 1998) and increased mortality due to substantial
increase in suicide risk relative to the general population (Schaffer et al., 2015). Most adults with
BD retrospectively report initial onset of mood symptoms in childhood or adolescence (e.g.,
(Chengappa et al., 2003; Goodwin & Jamison, 2007; Perlis et al., 2004) with the typical period
of onset between 18 to 22 years (Merikangas et al., 2007; Weissman et al., 1996). However,
pediatric bipolar disorder (PBD), or BD that onsets prior to age 18, was considered extremely
rare until very recently (Fristad & Algorta, 2013). Opinions regarding the prevalence of PBD
began to change when long-term follow-up of children treated for unipolar depression indicated
approximately 30% converted from unipolar depression to BD (Geller, Fox, & Clark, 1994) and
two larger cohorts of youth with PBD were prospectively identified in the early 1990s
(Biederman et al., 1996; Geller, Fox, & Fletcher, 1993). Over the next decade, the rate of clinical
diagnosis of PBD increased dramatically (Blader & Carlson, 2007; Moreno et al., 2007). The rate
of PBD diagnosis in the U.S. has not been examined since 2004, and it is unknown whether the
rate of diagnosis has stabilized, declined, or continued to increase since the mid-2000s.
Therefore, the purpose of the current paper is to examine whether the rate of clinical diagnosis of
PBD has continued to increase over the past decade.
PBD has been identified in the clinical literature for centuries. In the early 20th century,
Kraepelin described bipolar disorder as frequently occurring between ages 15 and 20 (Kraepelin,
1921). Throughout the 1970s and 1980s, case studies and case series identified youth with PBD.
The identification of youth in only case studies led many to believe that PBD was exceedingly
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rare (Carlson & Glovinsky, 2009). The subsequent increase in the rate of diagnosis in the mid1990s to mid-2000s caused many to believe that PBD was being over-diagnosed (Hirschfeld,
Lewis, & Vornik, 2003; Jenkins, Youngstrom, Washburn, & Youngstrom, 2011). As a result of
this worry, the DSM-5 introduced the new diagnosis of disruptive mood dysregulation disorder
(American Psychiatric Association, 2013) to potentially decrease the diagnosis of PBD in
clinical settings. However, large increases in clinical diagnoses can occur for many reasons. First
and foremost, changes in genetic, biological, or environmental risk factors may occur and can
result in both increases and decreases in prevalence. Besides true changes in prevalence, the rate
of diagnosis can also increase if case-finding improves due to clinician awareness. Prevalence
may also increase due to changes in (a) diagnostic definitions and standards; (b) diagnostic
substitution; and (c) changes in availability of services (i.e., FDA approved medicine). The
precise reason for why a change in prevalence is occurring can be difficult to ascertain unless
certain conditions are met.
Change in the Rate of PBD Diagnosis
Outpatient.
Most studies examining the rate of change of PBD diagnosis in the United States
examined changes between approximately 1994 and 2004. For example, between 1995 and 2000
the rate of outpatient billing claims for PBD increased from 90 to 150 per 10,000 billing claims
in a nationally representative sample of private insurance claims for youth 0 to 18 years (HarpazRotem & Rosenheck, 2004). Analysis of the National Ambulatory Medical Care Survey, a
random sampling of U.S. outpatient physicians, assessed rates of PBD diagnosis between 1994
and 2003 and found an increase in diagnosis from 2.5 to 100.3 per 10,000 population among
outpatient youth ages 0 to 19 (Moreno et al., 2007). Additionally, the percentage of outpatient

2

visits with a diagnosis of PBD increased from .01% to .44% out of the total outpatient visits.
Analyses based on private insurance data indicate an almost doubling of risk of PBD diagnosis,
while the more comprehensive national data suggests risk increased approximately forty-fold. In
summary, the rate of outpatient PBD diagnoses increased over a ten-year period.
Inpatient.
An increase in the rate of clinical diagnosis of PBD also occurred in inpatient units
during the same time period. In a sample of privately insured youth admitted to inpatient
psychiatric facilities, the rate of PBD diagnosis increased from 1,060 to 1,840 per 10,000 youth
between 1995 and 2000 (Harpaz-Rotem, Leslie, Martin, & Rosenheck, 2005). Blader and
Carlson (2007) examined rates of BD diagnosis among inpatient children, adolescents, and adults
between 1996 and 2004, using discharge rates from the National Hospital Discharge Survey.
Results indicated that the rate of PBD diagnosis among children ages 5 to 13 increased from 1.3
to 7.3 per 10,000. The rate of PBD diagnosis among adolescents ages 14 to 18 increased from
5.1 to 20.4 per 10,000. The increase in the rate of BD diagnosis was significantly greater among
youth than the increase for adults. Furthermore, hospitalization was more prevalent in this
sample among male compared to female children (ages 5 to 13), but by adolescence (ages 14 to
18) hospitalization was more prevalent among females compared to males. The rate of diagnosis
of PBD also increased by 1.9 times in youth with private insurance (Blader & Carlson, 2007).
Similar to outpatient data, the rate of diagnosis of PBD in U.S. inpatient units increased over the
same decade but at a higher rate.
Research on changing trends in diagnostic rates using samples from the U.S. ended at the
peak of the PBD diagnostic phenotype debate. Many European scholars have argued that PBD
was an American concern (James et al., 2014; Parry & Richards, 2014). However, two analyses
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using data from the nationwide German inpatient healthcare system examined continued change
in rates of PBD diagnosis between 2000 and 2013 (Holtmann et al., 2010; Rao et al., 2016).
Holtmann and colleagues (2010) identified an increase from 0.113 to 0.191 per 10,000 in PBD
diagnosis between 2000 and 2007 among hospitalized youth under age 19 years. Change in the
PBD diagnostic rate varied by age with younger youth (< 15 years) displaying no change in the
rate of PBD diagnoses but older adolescents (15-19 years) displaying a large increase in the rate
of PBD diagnoses. Rao and colleagues (2016) subsequently compared these findings with data
from the same nationwide inpatient database to determine continued change between 2008 and
2013. The rate of diagnosis of PBD in children (< 15 years) did not significantly increase (0.2 to
0.3 per 100,000), while the rate of diagnosis among older adolescents (15 – 19 years) increased
from 6.56 to 8.14 per 100,000 adolescents. Proportionally, the rate of PBD diagnosis increased
from 0.26 to 0.27 of all psychiatric diagnosis in the German inpatient healthcare system between
2008 and 2013 (Rao et al., 2016). These findings suggest either: (a) risk factors for PBD are
changing in Germany as well as the U.S., or (b) if one assumes that earlier U.S. increases also
apply to Germany then the rate of PBD diagnosis has also increased. Of note, the German
healthcare system is markedly different from the U.S. health care system, and provider incentives
for diagnosis are likely to differ dramatically (Stringaris & Youngstrom, 2014). Therefore, it is
possible that trends in the rate of PBD diagnosis may have differed between the U.S. and
Germany over the past decade.
Implications.
Findings regarding the increase in PBD diagnosis were presented in terms of relative risk
at the time of publication. For example, Moreno and colleagues (2007) indicated a 40-fold
increase in the proportion of office visits for PBD (i.e., 0.01 to 0.44%) as a proportion of all
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outpatient office visits. The presentation of this finding as a 40-fold increase in the proportion of
office visits for PBD led to concerns about the potential over-diagnosis of PBD. However, when
considered in terms of absolute risk, a 40-fold increase from 0.01% is quite small. Furthermore,
this increase was not considered within the context of broader epidemiological findings. In
particular, the epidemiological base rate for the spectrum of pediatric bipolar disorders has been
estimated at 1.8%, with the prevalence rate rising to 2.7% when considering only youth age 12 or
older (Van Meter, Moreira, & Youngstrom, 2011). While the rate of PBD diagnosis per 10,000
youth increased dramatically between the mid-1990s to mid-2000s, this rate still remained below
the estimated epidemiological base rate of PBD. Changes in the rate of inpatient PBD diagnosis
identified by Blader and Carlson (2007) also remained below the estimated epidemiologic base
rate of PBD. While PBD diagnosis increased between 1996 and 2004, the risk of PBD diagnosis
associated with an outpatient visit remained well below what would be expected given
epidemiological base rates. Therefore, a portion of youth with PBD identified in epidemiological
samples may still not have received services during this time.
Changes in Diagnostic Rates of Other Disorders
Much of the concern regarding the increase in PBD diagnosis views the increase in
relative isolation. However, other pediatric psychiatric disorders have seen changes in diagnostic
rates similar to or greater than PBD. For example, between 2000 and 2007, an increase in
depressive disorder diagnosis from 1.3 to 4 per 10,000 admissions was identified for youth ages
0 to 19 using data from the German inpatient healthcare system (Holtmann et al., 2010). A
follow up to this study compared data collected between 2008 and 2013 with the original data
collected between 2000 and 2007 and identified a total increase from 1.3 to 10.4 per 10,000
admissions in the rate of depressive disorder diagnosis between 2000 and 2013 (Rao et al.,
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2016). During this time period, the rate of diagnosis of depression in youth increased
approximately eightfold, relative to twofold for PBD. Therefore, clinicians working in inpatient
psychiatric units might be diagnosing all mood disorders in youth more frequently.
While it is possible that clinicians are simply more willing to diagnose mood disorders, it
is also possible that the stigma associated with the use of more severe diagnoses has decreased
and clinicians have become more willing to use diagnoses indicating more severe
psychopathology. For example, in the same dataset used to identify change in the rate of PBD
diagnosis, Blader and Carlson (2007) also identified a significant increase in the rate of diagnosis
of conduct-related disorders between 1996 and 2004. In particular, the rate of diagnosis of
conduct-related disorders increased by 6.2% among children and 12% among adolescents
nationally during this time period (Blader & Carlson, 2007). Therefore, the increase in PBD
diagnosis may simply reflect an increase in clinicians’ willingness to diagnose more severe
psychopathology in inpatient units.
Reasons for Changes in Prevalence Rates
The increased prevalence of PBD in clinical settings has stirred substantial debate
regarding the appropriate diagnosis of BD in children and adolescents. For example, the DSM-5
included disruptive mood dysregulation disorder with the hopes of decreasing PBD diagnosis in
children and adolescents (American Psychiatric Association, 2013). However, the changes in the
rate of PBD diagnosis should be considered in the greater context of the identification of
disorders and diseases. Cancer and autism spectrum disorders (ASD) provide two worthwhile
comparators because the epidemiological surveillance of the clinical prevalence of both illnesses
has greater longevity than PBD. The clinical diagnosis of some subtypes of cancer have
increased while others have decreased in the prior two decades. For example, the clinical
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prevalence of prostate cancer diagnosis increased dramatically from a relatively undiagnosed,
unrecognized disease to a more easily identified illness with the introduction of PSA screening.
Similarly, the rate of ASD diagnosis increased between 7.5 and 15 fold between 1966 and the
early 2000s (4 per 10,000 to 30 – 60 per 10,000; Fombonne, 2003; Rutter, 2005). Therefore, the
changes in the clinical prevalence of PBD diagnosis may not be due to over-diagnosis, but
reflective of broader changes related to clinical service provision, such as increased availability
of effective screening tools.
In both cancer and ASD surveillance, the reasons for changes in the clinical prevalence of
the illnesses have been given substantially greater thought than in PBD. In particular, changes in
the rate of screening, classification, and risk exposure are likely causes of changes in the
prevalence of cancer (Ward, Thun, Hannan, & Jemal, 2006). For example, improved
classification of esophageal cancers by cell type instead of bodily region indicated that while the
overall prevalence of esophageal cancers has increased slightly, some types (e.g., squamous cell
carcinoma) decreased while other types increased (e.g., adenocarcinoma; Vizcaino, Moreno,
Lambert, & Parkin, 2002). Exposure to risk factors also affects the true rate of illness. For
example, as the prevalence of smoking has decreased, so too has the prevalence of lung cancers
(Govindan et al., 2006). However, for illnesses not clearly marked by definable biological tests
such as ASD and PBD, additional factors might also play a role in the rate of change of
diagnosis. In addition to changes in the screening, classification, and risk factors, mental health
diagnoses are also likely subject to changes in the availability of services, pattern of referrals,
increased public awareness, and changes in diagnostic definitions (Fombonne, 2003). For
example, many ASD observers believe that the increase in the rate of autism diagnosis is most
likely due to external factors related to service provision, awareness, and changes in diagnostic
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definitions and not directly due to a large increase in the actual incidence of autism from changes
in risk factors (Hansen, Schendel, & Parner, 2015; Rutter, 2005). Therefore, if PBD experienced
a period of a broader diagnostic definition, increased awareness, and an increase in the
availability of assessment tools and interventions, then an increase in the clinical diagnosis of
PBD should be expected. At the same time that the clinical prevalence of PBD increased from
the mid-1990s to the mid-2000s, all of these external risk factors occurred making it more
difficult to link the change in PBD diagnostic rates to any specific reason for such a change.
Changes in the Diagnostic Standard.
BD in adults is defined as an illness of distinct episodes with changes in mood and energy
(American Psychiatric Association, 2013; World Health Organization, 1992). Despite diagnostic
manuals and many textbooks implying that adults with BD present with distinct mood episodes
separated by periods without mood symptoms, approximately half of adults with BD have
subthreshold symptoms between mood episodes (Perlis et al., 2006). Similarly, most youth with
PBD present with subthreshold symptoms between episodes (Birmaher, Axelson, Goldstein, et
al., 2009; Birmaher et al., 2006; DelBello, Hanseman, Adler, Fleck, & Strakowski, 2007; Geller,
Tillman, Bolhofner, & Zimerman, 2008). Early work examining the phenotype of PBD
emphasized its chronic course (Birmaher et al., 2006). One such instantiation is the ‘broad’
phenotype of PBD. The ‘broad’ phenotype emphasized chronic presentation marked by the
presence of severe, chronic irritability (Biederman et al., 2004). While the broad phenotype
garnered clinical support because it represents a set of severely dysregulated and impaired youth,
the lack of distinct episodes concerned many. The broad phenotype represented a non-episodic
presentation in contrast to the historical description of BD as an episodic syndrome.
Additionally, the broad phenotype focused on the presence of severe irritability as the principal
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symptom of mania and youth did not need to present with more specific symptoms of mania such
as grandiosity, elated mood, or decreased need for sleep (Leibenluft, Charney, Towbin, Bhangoo,
& Pine, 2003; Youngstrom, Birmaher, & Findling, 2008). The potential symptoms of mania that
were also symptoms of other disorders (e.g., irritability, increased energy) led to concerns about
misdiagnosis of PBD. Therefore, a ‘narrow’ phenotype was proposed as a more restricted
alternative to the broad phenotype.
The narrow phenotype of PBD focuses on the presence of specific symptoms of mania.
The narrow phenotype requires elated mood or grandiosity and typically also requires the
presence of a clear episode which lasts for a period of at least one week (Geller et al., 2002;
Leibenluft et al., 2003). Under this phenotype, irritable mood is insufficient on its own to meet
criteria for mood disturbance in the narrow phenotype because irritability could arise due to
many different presenting concerns. The use of an “and” rule and the exclusion of irritability as a
symptom of mania creates a more restrictive definition that may ignore a subset of cases (Sharma
et al., 2016; Washburn, West, & Heil, 2011). Therefore, an ‘intermediate’ phenotype attempted
to compromise between the narrow and broad definitions of pediatric mania.
The intermediate phenotype is consistent with DSM and International Classification of
Diseases (ICD; World Health Organization, 1992) diagnostic criteria. The intermediate
phenotype also includes the entire spectrum of BD (i.e., bipolar I, bipolar II, cyclothymia, and
OSBARD) by accounting for even brief duration episodes of manic symptoms such as 1-3 days.
The intermediate phenotype also includes irritable mood as a cardinal symptom of mania even if
no elevated mood is present, as long as duration and other diagnostic criteria are met (Leibenluft
et al., 2003; Pavuluri, Birmaher, & Naylor, 2005). Research using the intermediate phenotype
indicates that characteristics of PBD are generally consistent with adult presentations of BD

9

except that youth with PBD tend to have longer duration episodes and more irritable mood
(Youngstrom, Birmaher, & Findling, 2008). Additionally, youth with PBD often exhibit high
levels of functional impairment (Freeman et al., 2009) and have a family history of mood
disorders (Birmaher et al., 2006).
While some differences between PBD and adult BD exist, substantial overlap between
the two diagnoses has been identified. A meta-analysis of 20 studies of PBD phenomenology
indicated that approximately 79% of youth with PBD presented with increased energy, 57% had
grandiosity, and other symptoms of mania ranged from being present in 54% to 77% of youth
with PBD (Van Meter, Burke, Kowatch, Findling, & Youngstrom, 2016). This continuity
between child and adult phenotypes of BD suggests that the clinical presentation of PBD may be
similar to adult BD for many youths. As a result, a consensus around a DSM-oriented model of
PBD using the intermediate phenotype has recently developed (Carlson & Glovinsky, 2009;
Robert A. Kowatch, Youngstrom, Danielyan, & Findling, 2005; Van Meter et al., 2016). Prior to
this consensus, the debate surrounding the PBD phenotype may have influenced the criteria used
to diagnose PBD in clinical practice. Clinicians may have based diagnoses on either the broad,
narrow, or intermediate phenotypes. In particular, if clinicians used the broad phenotype during
this time, the rate of diagnosis of PBD would be expected to increase because the broad
phenotype substantially expanded diagnostic criteria. Given these concerns, questions arose
about the extent to which the rate of clinical PBD diagnosis had changed prior to the resolution
of the phenotype debate.
Changes in Awareness.
From the mid-1990s to the mid-2000s, there was a dramatic increase in public awareness
related to the PBD diagnosis (Lofthouse & Fristad, 2004). One metric of public awareness is
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how often a term is searched on the internet. Google trends suggests bipolar disorder is being
searched less often since the mid-2000s than prior to the mid-2000s (Fond, Gaman, Brunel,
Haffen, & Llorca, 2015), suggesting that heightened public awareness of PBD prior to the mid2000s likely occurred simultaneously with the increase in the rate of diagnosis of PBD. Similar
increases in awareness have been observed for other psychiatric disorders. For example, the rate
of ASD diagnosis has continued to increase concurrently with the increase in public awareness
about the disorder. While public searching for BD has decreased since the mid-2000s, Google
trends indicates that public searching for ASD has remained relatively stable and the rate of
diagnosis of ASD has continued to increase. It is possible that the rate of diagnosis of PBD has
not continued to increase in the same manner given the decline in public awareness of BD since
the mid-2000s. Therefore, it is important to assess the rate at which PBD has been diagnosed
over the past decade to determine whether there is need for concern regarding continued increase
of PBD diagnosis.
Changes in Assessment Methods.
Development of effective screening tools can have a substantial impact on the rate at
which an illness is diagnosed (e.g., as in cancer and ASD diagnosis). Prior to the mid-1990s,
evidence-based assessment tools for diagnosing PBD were limited. As part of the increased
scientific awareness of PBD, researchers focused on improving methods for assessing PBD.
These advances included structured and semi-structured clinical interviews, self-report measures
and informant-report measures with questions specifically designed to assess mania symptoms.
For example, the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS; PuigAntich & Chambers, 1978), a semi-structured interview initially developed in the 1970s to assess
for a variety of psychiatric symptoms using DSM-III criteria, was revised repeatedly to improve
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the bipolar disorders diagnostic section (Ambrosini, 2000; Geller et al., 2001). Structured and
semi-structured clinical interviews adapted for the assessment of mania in youth aided
researchers and clinicians in consistently identifying cases of PBD.
Previously adult-focused self-report measures of mania were also adapted to facilitate
youth and caregiver self-report. For example, a parent-report version of the Young Mania Rating
Scale (P-YMRS) was developed and showed good discriminative validity in identifying cases of
PBD compared to unipolar depression, disruptive behavior disorders, and other clinical
diagnoses (Gracious, Youngstrom, Findling, & Calabrese, 2002). In addition to clinical
interviews and rating scales, the importance of using setting-specific base rates and family
history of BD as factors in evidence-based decision-making was instituted during this time
period (Youngstrom, Findling, Kogos Youngstrom, & Calabrese, 2005). The introduction of
effective screening tools and evidence-based assessment techniques may have led to more
accurate identification of PBD cases, thereby impacting the rate at which PBD was diagnosed.
Another potential outcome of evolving assessment methods is diagnostic substitution,
which occurs when an individual diagnosed with ‘disorder A’ is later re-diagnosed with ‘disorder
B,’ which takes the place of the original diagnosis. Diagnostic substitution is common among
patients who receive an eventual BD diagnosis. Individuals with BD often experience long
durations between receiving an initial psychiatric diagnosis (e.g., major depressive disorder) and
receiving a diagnosis of BD (Hirschfeld et al., 2003; Lish, Dime-Meenan, Whybrow, Price, &
Hirschfeld, 1994). With the advent of more effective screening measures between the mid-1990s
to mid-2000s, many youths initially diagnosed with another psychiatric disorder may have
experienced diagnostic substitution for a bipolar spectrum disorder upon re-evaluation, causing
the rate of diagnosis of PBD to increase. However, mania typically onsets after depression
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(Birmaher, Axelson, Strober, et al., 2009). Therefore, diagnostic substitution might also reflect
the “typical” developmental onset of the disorder in which youth are initially diagnosed with
depression but then later display symptoms of mania. During the period of diagnostic increase
from the mid-1990s to mid-2000s, increased awareness and methods for detecting subthreshold
mania symptoms may have increased the diagnostic transition from unipolar to bipolar
depression. Since then, screening tools for PBD have been continuously refined. It is possible
that with the development of more effective screening tools, cases of PBD may have been
captured earlier in childhood or adolescence, potentially leading to a decrease in diagnostic
switching over the past decade.
Changes in Interventions.
The availability of pharmacological interventions for PBD also increased between the
mid-1990s and mid-2000s. Findings from open-label trials and retrospective chart reviews
suggested that mood stabilizing medications and second-generation antipsychotics may be
effective in treating symptoms of PBD (Biederman et al., 2005; Frazier et al., 1999; Kowatch,
Sethuraman, Hume, Kromelis, & Weinberg, 2003; Schreier, 1998). Placebo-controlled trials of
pharmacological intervention for youth with PBD were also completed during this time with
promising results (Kowatch et al., 2005). These interventions represented promising treatment
options for youth with PBD receiving services in both inpatient and outpatient settings.
Furthermore, compared to other countries, U.S.-based mental health providers may be
incentivized to assign diagnoses if effective treatment options are available in order to receive
reimbursement for services (Stringaris & Youngstrom, 2014). As the availability of
pharmacological interventions for PBD increased, the rate at which clinicians were willing to
provide a diagnosis of PBD may have increased between the mid-1990s to mid-2000s. However,
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given evolving reimbursement practices and a potential decrease in public awareness of PBD, it
is unknown whether youth continued to be referred for treatment at an increased rate over the
past decade.
Although the rate of change of PBD diagnosis has been assessed in Europe through 2013,
potential changes in the rate of PBD diagnosis in the U.S. post-2004 have not been examined.
Given the continued concern about overdiagnosis of PBD in the U.S., it is important to identify
whether the rate of diagnosis of PBD has continued to change over the past decade. Therefore,
the purpose of the current study was to examine the trajectory of PBD diagnosis after 2004 using
national- and state-level inpatient data.
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Chapter 2: Method
Study 1. National Sample
Data Source.
Data for Study 1 included health information collected via the National Hospital
Discharge Survey (NHDS) conducted annually by the National Center for Health Statistics
(https://www.cdc.gov/nchs/data/series/sr_01/sr01_039.pdf). NHDS data is nationally
representative based on a national probability sample of discharges from short-stay hospitals
(i.e., average length of hospitalization less than 30 days for all patients) or general hospitals or
children’s hospitals regardless of length of stay. Psychiatric hospitals are typically included
under the short-stay hospital criteria. Hospitals were selected via three stages that are described
in detail by Dennison and Pokras (2000). In the third stage, discharges were selected from each
hospital using stratified random sampling for coding. The number of cases was between one and
five percent of discharges with a minimum of 250 discharges annually.
Data collected between 1996 and 2010 are de-identified and publicly available for
download and analysis at the individual patient level. NHDS data includes patient diagnoses,
age, gender, race, discharge year, geographic region, and type of insurance coverage. Each
observation includes a weight that allows one to estimate the prevalence in the population (e.g.,
number per 10,000 persons).
Statistical Analyses.
All data analysis was conducted in R (R Core Team, 2013). Cases were limited to those
with a primary diagnosis of a psychiatric disorder. This approach was used to exclude
individuals hospitalized for physical health reasons who also have a psychiatric illness (e.g., a
person hospitalized for an appendectomy who also had a diagnosis of major depressive disorder).
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PBD was the focal diagnosis of all analyses. However, to better place the PBD findings in
context, analyses were also repeated for youth with a primary diagnosis of a unipolar depressive
disorder (DD) and for overall hospitalizations. Summing the weights of all cases in which a
psychiatric disorder appeared as the primary diagnosis yielded an estimate of the total number of
discharges from acute care facilities during the survey year. Dividing this estimated total number
of discharges by the corresponding year’s U.S. population estimate for each age group permitted
computation of annual hospitalization rates for children, adolescents, and adults.
For PBD and DD, two indices were calculated from the NHDS data to represent rates of
psychiatric diagnoses. Each index was computed for PBD and DD. The indices were: (a)
proportion of psychiatric discharges with a primary diagnosis of PBD, and (b) the rate of PBDrelated discharges per 10,000 persons in the general population for the respective age group. For
overall hospitalization trends, the following two indices were examined: (a) the proportion of all
psychiatric hospitalizations relative to physical health hospitalizations and (b) the rate of
psychiatric hospitalizations per 10,000 persons. Consistent with recommended practices, data
were initially be screened for out-of-range values, plausible means and standard deviations, and
univariate outliers (Tabachnick & Fidell, 2007).
To examine the change in the proportion of youth being diagnosed with PBD, a series of
chi-squared tests were conducted. To examine the overall trend in PBD diagnoses, the proportion
from 1996 was compared to the proportion from 2010. To replicate Blader and Carlson (2007),
the proportion of PBD cases from 1996 was compared to the proportion of PBD cases from
2004. To test whether a change in proportion occurred, the proportion of cases from 2004 was
compared to the proportion of cases in 2010. The analyses were repeated for proportions for DD
and overall psychiatric hospitalization.
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To test whether the population-adjusted rate of PBD diagnosis changed over time, a
series of linear regression analyses with multiple predictors were conducted. Models were fit
hierarchically to predict the rate of PBD diagnosis from survey year and age group. Age group
was examined by using adolescents as the reference group in comparison with children and
adults. The assumptions of regression (i.e., linear relationship, homogeneity of variance, and
normality of residuals) were examined via a series of plots. Analyses were repeated for DD and
overall psychiatric hospitalization.
A series of logistic regressions were conducted that examine the ratio of PBD to other
psychiatric hospitalization diagnoses. Models were fit hierarchically to predict PBD diagnosis
from survey year, age, gender, race, U.S. region of the reporting facility, and type of health
insurance coverage. Age group was examined by using adolescents as the reference group in
comparison with children and adults. To examine gender, women were coded as 0 and men were
coded as 1. Patients who identified as White were coded 0 and patients who identified as
African-American were coded as 1. Government-funded insurance (e.g., Medicaid) was coded as
0 and private insurance was coded as 1. Deviation coding was used to assess each geographic
region (i.e., South, West, Midwest, and Northeast) compared to the mean of all geographic
regions. This set of analyses was repeated for DD as well.
Study 2. State-Level Sample
Data Source.
Data for Study 2 included Medicaid billing claims from five psychiatric inpatient
hospitals in Nevada. De-identified billing claims were obtained from the Center for Health
Information Analysis (https://chia.unlv.edu) and included claims for 48,108 unique inpatient
admissions between 2005 and 2015 for youth ages five to 17. Diagnoses were reported for each
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claim using ICD-9 codes. Mood disorder diagnoses were classified into two groups: 1) PBD or
2) DD. PBD was classified using codes 296.00 - 296.06; 296.40 - 296.46; 296.50 - 296.56;
296.60 - 296.66; 296.70; 296.80; 296.81; 296.89; and 301.13. DD was classified using codes
296.20 - 296.26; 296.30 - 296.36; 300.4; 311.00; and 625.4. Additional variables in this dataset
included gender, year, and hospital of admission.
Statistical Analyses.
Data were analyzed using the R statistical software. As in Study 1, PBD was the focal
diagnosis of all analyses. To place the PBD findings in context for Study 2, analyses were again
repeated for youth with primary diagnoses of DD. Admissions rates for each diagnostic group
were converted to rate per 1,000 admissions per hospital per year. Linear regression was used to
assess whether the rate of PBD diagnosis changed over time. Gender was subsequently added to
the model to evaluate whether gender impacted the change in the rate of diagnoses over time,
given that there are gender differences in the prevalence of mood disorders, particularly
depression (Angst et al., 2002; Kuehner, 2003). A three-stage hierarchical multiple linear
regression analysis was conducted to predict the rate of PBD diagnosis from year, gender, and
the interaction between year and gender. An identical three-stage hierarchical regression model
was conducted to evaluate the rate of diagnosis of DD. To ease the interpretation of the models,
year was centered on 2005 so that data from 2005 had a year equal to 0, 2006 had a year equal to
1, and so on. Gender was dummy coded as ‘0’ for males and ‘1’ for females.
To account for clustering of diagnostic rates within hospitals over time, the clusteradjusted variance-covariance matrix was used to obtain estimates of the standard error, t-value,
and significance value for each level of the regression models. The cluster-adjusted variancecovariance matrix was also used to obtain the 95% confidence interval for the estimates of each
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predictor. The F-statistic for each level of the models was obtained using the Wald test. R2 and
the change in R2 were obtained from each of the original models, as R2 does not change even if
the errors are clustered. R2 is calculated using the sums of squares, which become irrelevant once
the variance-covariance matrix is used to account for clustering. However, R2 is still useful as a
measure of goodness-of-fit even after using the corrected variance-covariance matrix to obtain
new standard error and t-value estimates.
The assumptions of regression (i.e., linear relationship, homogeneity of variance, and
normality of residuals) were examined via a series of plots. Following visual examination of the
data, the trend in diagnostic rates for the PBD and DD groups appeared nonlinear. As such, a
second three-stage hierarchical multiple linear regression model was conducted to determine
whether adding polynomial regression coefficients was meaningful. An identical model was
conducted for the DD group. The cluster-adjusted variance-covariance matrix was again used to
obtain estimates of the standard error, t-value, and significance value for each level of the
regression models. R2 and the change in R2 were obtained for each level of the models to
determine the overall variance accounted for after adding each polynomial regression coefficient.
The F-statistic for each level of the model was obtained using the Wald test.
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Chapter 3: Results
Study 1. National Sample
Changes in Proportions of Diagnoses.
Between 1996 and 2010, 6.97% of all inpatient hospitalizations for individuals ages five
and older were associated with a primary psychiatric diagnosis. The proportion of psychiatric
hospitalizations initially increased from 6.76% in 1996 to 7.09% in 2004 (c2(1) = 23.36, p =
.003) and decreased to 6.35% in 2010, c2(1) = 96.98, p < .001 resulting in a decline in the
proportion of psychiatric diagnoses to overall hospitalizations between 1996 (6.76%) and 2010
(6.35%), c2(1) = 24.41, p = .002. However, the overall proportion of psychiatric hospitalizations
to all inpatient hospitalizations masks age-specific differences. Adults (> 18 years old) were most
similar to the overall trajectory. For adults, psychiatric hospitalizations represented 6.50% of all
adult hospitalizations in 1996 and this remained stable in 2004 at 6.64% (c2(1) = 3.96, p = .22)
before declining to 5.72% in 2010, c2(1) = 149.07, p < .001. In contrast, both children (5-13
years old) and adolescent (14-18 years old) proportions increased during the same time period.
For adolescents, the proportion of psychiatric hospitalizations to all hospitalizations increased
from 13.19% in 1996 to 18.97% in 2004 (c2(1) = 109.09, p < .001) and increased again to
22.04% in 2010, c2(1) = 18.00, p = .009. The proportion of psychiatric hospitalizations for
children grew from 7.55% of all child hospitalizations in 1996 to 9.72% in 2004 (c2(1) = 25.10,
p < .001) and continued to increase to 16.12% in 2010, c2(1) = 106.09, p < .001. In summary, the
overall decrease in the proportion of psychiatric diagnoses relative to all inpatient diagnoses was
driven by a decrease in the adult psychiatric hospitalizations, while psychiatric hospitalizations
increased for children and adolescents during the same time period.
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Bipolar Disorder.
Fourteen percent of all psychiatric hospitalizations were associated with a primary
diagnosis of BD between 1996 and 2010. BD-related admissions increased from 9% of all
psychiatric hospitalizations in 1996 to 15% in 2004 (c2(1) = 326.62, p < .001) and continued to
increase to 17% in 2010, c2(1) = 11.65, p = .03. Figure 1 compares the proportions of all
psychiatric hospitalizations with a diagnosis of BD, DD, or other non-mood disorder diagnoses
by age group. Adults were again similar to the overall trajectory in BD diagnosis. The proportion
of adult BD diagnosis increased from 9.21% of all adult psychiatric hospitalizations in 1996 to
13.94% in 2004 (c2(1) = 181.85, p < .001), and continued to increase to 15.34% in 2010, c2(1) =
11.30, p = .04. Adolescents were most similar to adults. The proportion of adolescent BD
diagnosis increased from 8.56% of all adolescent psychiatric hospitalizations in 1996 to 22.46%
in 2004 (c2(1) = 91.18, p < .001), and continued to increase to 27.93% in 2010, c2(1) = 9.36, p =
.03. In contrast to the continued increase in BD diagnosis for adults and adolescents, the
proportion of child BD diagnosis decreased between 2004 and 2010. The proportion of BDrelated hospitalizations increased from 8.31% of all child psychiatric hospitalizations in 1996 to
32.23% in 2004 (c2(1) = 105.19, p < .001), then decreased to 19.54% in 2010, c2(1) = 24.29, p <
.001. In summary, the continued increase in the proportion of BD diagnoses to all psychiatric
diagnoses between 2004 and 2010 was largely driven by adults and adolescents, while the
proportion of child BD diagnoses decreased during the same period.
Depressive Disorders.
The proportion of DD-related hospitalizations to all psychiatric hospitalizations between
1996 and 2010 was 23%, which was not significantly different from the proportion of BD-related
admissions during the same period, c2(1) = .04, p = .82. DD-related psychiatric admissions
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increased significantly from 22% to 24% between 1996 and 2010, c2(1) = 12.80, p = .02. In
contrast to BD, DD-related psychiatric hospitalizations initially remained relatively stable at 22%
in both 1996 and 2004 (c2(1) = 1.96, p = .39), and then increased to 24% in 2010, c2(1) = 27.86,
p = .001. Adults did not follow the overall trend in DD-related hospitalizations. The proportion
of adult DD diagnosis relative to all adult psychiatric diagnoses remained stable over time at
21.28% in 1996, 20.41% in 2004 (c2(1) = 3.06, p = .28), and 21.76% in 2010, c2(1) = 7.85, p =
.10. The proportion of adolescent DD-related hospitalizations relative to all adolescent
psychiatric hospitalizations followed a similar pattern. The proportion of adolescent DD
remained stable at 29.42% in 1996, 33.42% in 2004 (c2(1) = 4.85, p = .13), and 38.39% in 2010,
c2(1) = 6.34, p = .08. In contrast to adults and adolescents, the proportion of child DD diagnoses
compared to all child psychiatric diagnoses decreased from 32.48% of all child psychiatric
hospitalizations in 1996 to 20.32% in 2004 (c2(1) = 25.46, p < .001), followed by an increase to
35.32% in 2010, c2(1) = 31.33, p < .001. The trend in the proportion of child DD diagnoses
appears to have followed the opposite trend compared to child BD diagnoses. In summary, the
mild increase in the overall proportion of DD diagnoses between 1996 and 2010 occurred despite
relatively stable diagnostic practices in adults and adolescents. The diagnosis of DD in children
was variable during this time period.
Changes in Population-Adjusted Rates of Diagnoses.
Table 1 displays population-adjusted rates of diagnoses by age between 1996 and 2010.
Visual inspection of the longitudinal trajectory of population-adjusted rates of psychiatric
diagnoses suggested a trend that could be nonlinear. Therefore, a series of regression models
were fit hierarchically to test whether the change in the population adjusted rate of psychiatric
hospitalization per 10,000 persons was nonlinear. Table 2 displays the hierarchical regression
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results. Age group accounted for 77% of the variance in the population-adjusted rate of
psychiatric hospitalizations, p < .001. Therefore, age group was controlled for in all analyses.
After controlling for age group, year did not significantly predict the population-adjusted
rate of psychiatric hospitalizations between 1996 and 2010, DR2 = .01, p = .27. Despite a
significant improvement in model fit (DR2 = .02, p = .03), there was not a significant interaction
between age and year. A significant quadratic effect for year indicated that the populationadjusted rate of psychiatric hospitalizations increased between 1996 and 2006, followed by a
slight decrease between 2006 and 2010, DR2 = .12, p < .001. However, the quadratic effect was
moderated by age group, DR2 = .01, p < .001. As seen in Figure 2, the rate of psychiatric
hospitalizations for children increased between 1996 and 2002 but remained relatively stable
until 2010. The rate of psychiatric hospitalizations for adults increased mildly between 1996 and
2006, but then declined below 1996 levels by 2010. The rate of psychiatric hospitalizations for
adolescents increased rapidly between 1996 and 2006 before starting a decline through 2010. In
summary, the adult and adolescent age groups experienced a period of initial increase in
psychiatric hospitalizations followed by a decrease, while children experienced a period of initial
increase followed by stabilization in psychiatric hospitalization rates.
Bipolar Disorder.
Hierarchical regression models empirically tested whether the change in the population
adjusted rate of BD-related hospitalizations per 10,000 persons was nonlinear. Table 3 displays
the hierarchical regression results. Age group accounted for 59% of the variance in the
population-adjusted rate of BD diagnosis, p < .001. Therefore, age group was controlled for in all
analyses.
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After controlling for age group, the population-adjusted rate of inpatient BD diagnosis
increased mildly each year by .38 [.14, .61] diagnoses per 10,000 persons, DR2 = .08, p = .003.
After controlling for the main effects of age group and year, there was not a significant
interaction between age and year, DR2 = .02, p = .41. Adding a quadratic coefficient to year
significantly improved overall model fit, DR2 = .11, p < .001. As seen in Figure 3, when
controlling for age group, the population-adjusted rate of BD diagnosis increased between 1996
and 2006, followed by a decrease between 2006 and 2010. After controlling for the main effects
of age group, year, and year2, there was a trend toward a moderating effect of age group on the
quadratic effect of year, DR2 = .03, p = .07. In summary, the rate of BD diagnosis per 10,000
initially increased until the mid-2000s and then decreased through 2010 for all three age groups.
Depressive Disorders.
Hierarchical regression models empirically tested whether the change in the population
adjusted rate of DD-related hospitalization per 10,000 persons was nonlinear. Table 4 displays
the hierarchical regression results. Age group accounted for 79% of the variance in the
population-adjusted rate of inpatient DD diagnosis (p < .001) and was controlled for in all future
analyses.
After controlling for age group, year did not significantly predict the population-adjusted
rate of inpatient DD diagnosis, DR2 = .00, p = .18. However, after controlling for main effects of
age group and year, there was a significant interaction between year and the adult age group
(DR2 = .04, p < .001), indicating that the change in the rate of diagnosis for adults was
significantly different from the change in the rate of diagnosis for adolescents. The change in the
rate of diagnosis for children over time did not significantly differ from adolescents. Adding a
quadratic coefficient to year significantly improved overall model fit, DR2 = .15, p < .001. The
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quadratic effect of year was moderated by age group, DR2 = .01, p = .003. As seen in Figure 4,
the population-adjusted rate of inpatient DD diagnosis for children remained relatively stable
between 1996 and 2002 and then increased until 2010. In contrast, the population-adjusted rate
for adolescents increased between 1996 and 2003, then decreased until 2010. The rate of DD
diagnosis among adults displayed a slight decrease across the study period. In summary, the
population-adjusted rates of DD diagnosis were variable between age groups across the study
period.
Impact of Demographic Variables on Risk for Diagnoses.
Bipolar Disorder.
A series of logistic regression models examined the effect of demographic variables on
BD diagnosis. The demographic variables considered included age group, gender, race,
insurance type, and geographic region. Table 5 displays the results of the logistic regressions.
Age group was examined by using adolescents as the reference group in comparison with
children and adults. To examine gender, women were coded as 0 and men were coded as 1.
Patients who identified as White were coded 0 and patients who identified as African-American
were coded as 1. Government-funded insurance (e.g., Medicaid) was coded as 0 and private
insurance was coded as 1. Deviation coding was used to assess each geographic region (i.e.,
South, West, Midwest, and Northeast) compared to the mean of all geographic regions.
The first model examined the main effects of all demographic variables. After controlling
for other demographic characteristics, adults were 43% less likely to receive a BD diagnosis than
adolescents while children were not significantly different from adolescents in their risk for
receiving a BD diagnosis. Compared to women, men were 34% less likely to be assigned a BD
diagnosis. African-American individuals were 35% less likely to receive a BD diagnosis
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compared to White individuals. Risk for BD diagnosis also varied by geographic region.
Individuals living in the South and Midwest were 30% and 10% times more likely to receive a
BD diagnosis compared to the average, respectively. In contrast, individuals living in the West
were 20% less likely to receive a BD diagnosis compared to average. There was no difference in
the odds of receiving a BD diagnosis by insurance type. In summary, race, gender, and
geographic region altered an individual’s risk for BD, while insurance status did not affect risk.
After controlling for main effects of all demographic variables, interactions between the
demographic variables and time were examined. First, interactions between year and age group
were assessed. The odds of receiving a BD diagnosis initially increased and then decreased at a
more rapid rate for children compared to adolescents. In contrast, the odds of receiving a BD
diagnosis increased and then decreased more slowly for adults relative to adolescents. Second,
interactions between gender with year and age group were examined. Gender significantly
interacted with the quadratic effect of year, such that the likelihood of receiving a BD diagnosis
increased for both men and women until 2004, at which time it remained stable for women but
decreased for men by 2010. There was no significant difference in the odds of BD diagnosis
between boys and girls in the child age group, and this was not significantly different from the
adolescent age group. However, adult men carried lower odds of receiving a BD diagnosis
compared to adult women during the study period (Figure 5). In summary, the odds of receiving
a BD diagnosis varied by age group throughout the study period. The odds of BD diagnosis by
gender were significantly different between men and women in the adult age group.
A third model evaluated interactions between year, race, and age group. The odds of
receiving a BD diagnosis increased at a greater rate for African-American individuals across the
study period compared to White individuals. There was also a significant interaction between
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race and age group during the study period, such that African-American adults carried lower
odds of BD diagnosis compared to African-American adolescents (Figure 6). In summary, race
significantly interacted with both year and age group to impact the odds of BD diagnosis.
A fourth model examined interactions between year, insurance type, and age group.
There was a significant interaction between insurance type and year, such that such that the
likelihood of receiving a BD diagnosis increased between 1996 and 2008 but remained stable
between 2008 and 2010 for individuals insured through a government program. In contrast, the
odds of BD diagnosis among privately insured individuals increased between 1996 and 2005,
then decreased through 2010. Insurance type also interacted with age group (Figure 7), such that
privately insured children were more likely to receive a BD diagnosis than their publicly insured
counterparts, which differed from adolescents. In summary, the odds of receiving a BD diagnosis
across the study period was impacted by significant interactions between insurance type, year,
and age group.
A final model assessed the interaction between year and geographic region. Geographic
region significantly interacted with year, such that individuals in the South were 1.12 times more
likely to be given a BD diagnosis compared to the average across the study period. In contrast,
individuals in the West and Midwest were 13% and 3% less likely to receive a BD diagnosis,
respectively. Geographic region also significantly interacted with the quadratic effect of year.
The likelihood of BD diagnosis for those residing in the South significantly increased until 2006
and then decreased through 2010. In contrast, the odds of BD diagnosis for those living in the
West remained relatively stable until 2002 and then increased through 2010. Risk of BD
diagnosis for individuals in the Midwest increased across the study period (Figure 8). In
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summary, the odds of receiving a BD diagnosis significantly varied by geographic region
throughout the study period.
Depressive Disorders.
Logistic regression models were repeated to examine the effect of demographic variables
on DD diagnosis. Table 6 displays the results of the logistic regressions. Trends in the main
effects of demographic variables on DD diagnosis were similar to the trends identified for BD. In
particular, individuals in the adult age group were 34% less likely to receive a DD diagnosis
compared to adolescents, while children did not significantly differ from adolescents in their risk
for receiving a DD diagnosis. Compared to women, men were 41% less likely to be given a DD
diagnosis. African-American individuals were 29% less likely to receive a DD diagnosis
compared to White individuals. Individuals living in the South and Midwest were 1.2 and 1.4
times more likely to receive a DD diagnosis compared to the average, respectively. In contrast,
individuals living in the West were 33% less likely to be assigned a DD diagnosis compared to
the average. In contrast with BD, privately insured individuals were 40% more likely to receive a
DD diagnosis compared to their publicly insured counterparts. In summary, race, gender,
geographic region, and insurance type altered an individual’s risk for DD.
After controlling for main effects of all demographic variables, interactions between the
demographic variables and year were examined. There were no significant interactions between
year with gender, race, and age group. However, race significantly interacted with age, such that
African-American adults carried a lower risk of receiving a DD diagnosis compared to AfricanAmerican adolescents (Figure 9). There was not a significant interaction between geographic
region and year. Potential interactions between insurance type with year and age group were also
examined. Insurance type interacted with year such that privately insured individuals carried
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increased odds of DD diagnosis compared to publicly insured individuals. However, the odds of
a privately insured person receiving a DD diagnosis decreased across the study period. Insurance
type also interacted with age group such that privately insured adults were more likely to receive
a DD diagnosis compared to privately insured adolescents (Figure 10). In summary, an
individual’s risk for DD was significantly altered by the interaction between race and age group,
as well as interactions between insurance type with year and age group.
Study 2. State Sample
There were 48,108 unique inpatient admissions for youth ages five to 17 between 2005
and 2015. Table 7 displays admissions counts and characteristics of the sample. The total number
of pediatric inpatient hospitalizations for any psychiatric diagnosis increased from 3,140 to 7,728
admissions between 2005 and 2015. Data from three hospitals were not available during all years
between 2005 and 2009. However, data from all hospitals were available between 2010 and
2015, during which time the overall number of pediatric hospitalizations increased from 4,659 to
7,728.
Bipolar Disorder.
We initially hypothesized that the rate of PBD diagnosis significantly decreased between
2005 and 2015. The rate of PBD diagnosis decreased from 207 to 111 per 1,000 admissions
between 2005 and 2015. Visual inspection of the longitudinal trajectory of PBD diagnostic rates
suggested a decrease between 2005 and 2015 that could be nonlinear. Therefore, three
polynomial regressions were fit hierarchically to empirically test whether the change in PBD
diagnostic rates was nonlinear. Table 8 displays the hierarchical regression results. Hospital of
admission accounted for 17% of the variance in the rate of PBD diagnosis, F(4, 44) = 1.86, p =
.14. Although not significant, hospital of admission was controlled for in all future analyses.
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After controlling for hospital of admission, the rate of PBD diagnosis significantly
decreased each year. Adding a quadratic or cubic coefficient did not significantly improve
overall model fit. Both the quadratic and cubic effects trended toward a rapid decrease in PBD
diagnosis with the cubic effect trending toward a slight increase in the final three years. Overall,
the rate of PBD diagnosis declined between 2005 and 2015 (Figure 9).
A second hierarchical regression analysis examined the interaction between year and
gender on the rate of PBD diagnosis over time. Table 9 displays the hierarchical regression
results. When including gender in the dataset, hospital of admission significantly accounted for
14% of the variance in the rate of PBD diagnosis. After controlling for hospital of admission, the
rate of PBD diagnosis significantly decreased each year. After controlling for hospital of
admission and year, gender was not associated with PBD diagnostic rates and there was not a
significant interaction between year and gender. Therefore, the rate of diagnosis of PBD
decreased between 2005 and 2015 for both boys and girls.
Depressive Disorders.
The rate of pediatric DD diagnosis increased from 284 to 429 per 1,000 admissions
between 2005 and 2015. Visual inspection of the longitudinal trajectory of DD diagnostic rates
suggested an increase between 2005 and 2015 that could be nonlinear. Therefore, three
polynomial regressions were fit hierarchically to empirically test whether the change in DD
diagnostic rates was nonlinear. Table 10 displays the hierarchical regression results. Hospital of
admission significantly accounted for 44% if the variance in the rate of DD diagnosis. Therefore,
hospital of admission was controlled for in all future analyses.
After controlling for hospital of admission, the rate of DD diagnosis significantly
increased each year. Adding a quadratic coefficient to the model indicated that the rate of DD
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diagnosis significantly increased quadratically over time. Specifically, DD diagnostic rates
decreased slightly between 2005 and 2008 and then increased dramatically between 2008 and
2015. Adding a cubic coefficient did not significantly improve overall model fit.
A second hierarchical regression analysis examined the interaction between year and
gender on the rate of DD diagnosis over time. Table 11 displays the hierarchical regression
results. When including gender in the data set, hospital of admission significantly accounted for
26% of the variance in the rate of DD diagnosis. After controlling for hospital of admission,
year, and gender, there was a significant interaction between year and gender. Simple slopes
analysis indicated that the slope of the rate of diagnosis for women (b = 13.03, p < .001)
significantly increased while the slope of the rate of diagnosis for men (b = -.40, p = .87)
remained stable over time. A final model examined the interaction between gender and the
quadratic trend of year. Adding a quadratic coefficient significantly improved overall model fit,
such that the rate of DD diagnosis for girls initially decreased between 2005 and 2008 followed
by a dramatic increase between 2008 and 2015. Figure 10 displays the interaction between
gender and the quadratic trend of year.
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Chapter 4: Discussion
The rate of PBD in the U.S. increased dramatically between the mid-1990s and mid2000s (Blader & Carlson, 2007; Harpaz-Rotem et al., 2005; Harpaz-Rotem & Rosenheck, 2004;
Moreno et al., 2007), resulting in concern regarding the potential for overdiagnosis of PBD
(Hirschfeld et al., 2003). However, given that the rate of PBD diagnosis had not been examined
in the U.S. since 2004, the continued longitudinal trajectory of the rate of PBD diagnosis was
unknown. Therefore, this study aimed to assess whether longitudinal changes in the rate of
inpatient PBD diagnosis continued to occur subsequent to 2004.
Blader and Carlson (2007) examined the rate of PBD diagnosis between 1996 and 2004
using a nationally representative dataset of inpatient hospital admissions. Study 1 extended
Blader and Carlson’s (2007) findings another 6 years to 2010 in order to assess whether the rate
of national inpatient PBD diagnosis increased, decreased, or remained stable between 1996 and
2010 with a particular focus on the period between 2004 to 2010. Study 2 utilized state-level data
to lengthen the period under analysis to 2015. These extensions were important because in the
mid-2000s scientific consensus developed around the intermediate diagnostic phenotype for PBD
(Carlson & Glovinsky, 2009; Kowatch et al., 2005; Van Meter et al., 2016) which may have
reduced the use of the broad PBD diagnostic phenotype in clinical practice. In addition, public
awareness of PBD may have decreased after the mid-2000s (Fond et al., 2015). Therefore, we
hypothesized that the rate of PBD diagnosis would decrease after 2004.
As a proportion of all national psychiatric hospitalizations, BD diagnosis increased across
the child, adolescent, and adult age groups until 2004. The proportion of BD diagnosis decreased
among children from 2004 to 2010, while the proportion of BD diagnoses to all psychiatric
hospitalizations increased among adolescents and adults during this period. In contrast to the
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proportion of BD diagnosis to psychiatric hospitalizations, the population-adjusted rate of
national BD-related hospitalizations significantly decreased from the mid-2000s until 2010 for
all age groups. This trend was particularly notable for children, given that the populationadjusted rate of overall psychiatric hospitalizations remained stable for children while the
population-adjusted rate of PBD diagnosis declined. In summary, while BD diagnoses came to
represent a greater proportion of inpatient psychiatric diagnoses among adolescents and adults
across the study period, the rate of BD-related hospitalizations in the general population
decreased from the mid-2000s to 2010 for all age groups.
The availability of the national data ended in 2010. State-level inpatient data examined
2005 to 2015 to provide a more recent window into inpatient psychiatric hospitalization
diagnostic trends. State-level data indicated that the rate of PBD diagnosis significantly
decreased among youth ages five to 17 between 2005 and 2015. However, youth ages five to 17
were grouped together into a single age category to facilitate the de-identified nature of the data.
It is therefore possible that trends in PBD diagnosis may be different between children and
adolescents in the state-level data, and that one age group may be driving the decline in PBD
diagnosis identified in our analyses.
Our findings contrast with recent international estimates of trends in PBD diagnosis. For
example, population-adjusted rates of PBD diagnosis among Danish youth increased between
1995 and 2003 (similar to the trend in the U.S.). However, the Danish rate of PBD diagnosis
continued to increase between 2004 and 2012 (Kessing, Vradi, & Andersen, 2014) in contrast to
the apparent decrease in PBD diagnosis over a similar time period in the U.S. Results from
German psychiatric inpatient units also contrasted with findings from the present study. In
particular, the population-adjusted rate of inpatient diagnosis of PBD in Germany remained
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stable among youth under age 15 from 2000 to 2013, but continuously increased for youth ages
15 to 19 and adults across the study period (Holtmann et al., 2010; Rao et al., 2016). This
contrasted with our data in which we observed significant initial increases followed by decreases
in the population-adjusted rate of BD diagnosis for children, adolescents, and adults. These
differences in diagnostic trends between countries also conflict with epidemiological data
suggesting that there is no significant difference in the actual prevalence of PBD internationally.
However, rates of clinical diagnosis of PBD appear to vary based on the diagnostic phenotype
(e.g., broad vs. narrow) used to classify cases of PBD (Van Meter et al., 2011). Therefore, it is
possible that discrepancies in rates of PBD diagnosis between the U.S. and other countries may
be due to differences in diagnostic definitions used to classify PBD rather than a true difference
in prevalence.
In addition to identifying the longitudinal trajectory of PBD, the present study also aimed
to compare it with the longitudinal trajectory of inpatient DD diagnosis. Results of Study 1
indicated that the population-adjusted rate of DD diagnosis among adolescents in the U.S.
initially increased until the mid-2000s and then decreased until 2010. However, DD diagnosis in
U.S. children increased between the mid-2000s and 2010, while the rate of DD diagnosis in
adults decreased across the study period. At the state level, the rate of DD diagnosis for boys
remained stable between 2005 and 2015 but increased exponentially for girls between 2008 and
2015. Internationally, increases in the inpatient diagnosis of depressive disorders have been
identified among youth in the German national healthcare system. In particular, DD diagnosis
increased by 832% among youth ages 0 to 19 (Holtmann et al., 2010; Rao et al., 2016). These
findings suggest that longitudinal changes in diagnostic trends are not unique to PBD, and that
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the rate of diagnosis of pediatric depressive disorders significantly increased over the same time
period.
A number of factors could have led to changes in the rate of inpatient PBD diagnosis.
Significant concern about misdiagnosis of PBD (Hirschfeld et al., 2003) may have dissuaded
clinicians from assigning the PBD diagnosis in the U.S. subsequent to the mid-2000s. Concern
about overdiagnosis in particular may have resulted in diagnostic substitution, in which
individuals initially diagnosed with PBD were later assigned a different psychiatric diagnosis. In
the case of psychiatric conditions such as autism, diagnostic substitution has been implicated as
one potential driver of change in rates of clinical diagnosis (Bishop, Whitehouse, Watt, & Line,
2008). As rates of autism diagnosis have increased, rates of other developmental disorders, such
as language disorders, have decreased (Bishop et al., 2008; Jick & Kaye, 2003). Vedel Kessing
and colleagues (2015) examined the stability of PBD diagnosis among Danish youth between
1994 and 2012 via a national register which allowed for the tracking of repeated psychiatric
service contact for each patient. Some youth who did not receive a diagnosis of PBD at their
initial contact with psychiatric services were later assigned a PBD diagnosis at subsequent points
of contact. However, the opposite was also observed. In particular, of the youth who did receive
a diagnosis of PBD at the initial point of contact, 21% experienced diagnostic substitution to
other psychiatric disorders, such as major depression or schizophrenia, by the second point of
contact (Vedel Kessing et al., 2015). It is possible that diagnostic substitution may have occurred
similarly in the U.S. between PBD and other psychiatric diagnoses not included in the present
study, which may have contributed to declining rates of PBD diagnosis.
Another factor that may have resulted in declining rates of PBD diagnosis in the U.S.
over the past decade relates to changes in public awareness about PBD. The initial increase in
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PBD diagnosis from the mid-1990s to mid-2000s coincided with greater media and scientific
coverage related to PBD (Lofthouse & Fristad, 2004). However, BD has been searched less often
on the internet since the mid-2000s (Fond et al., 2015), it is possible that PBD is no longer at the
forefront of public awareness. A decline in public awareness of PBD could have resulted in
individuals being less likely to seek services related to PBD, leading to a decrease in clinical
diagnosis.
Although diagnostic substitution and decreased awareness of PBD since the mid-2000s
may have played a role in changing diagnostic rates, inpatient prevalence of PBD may have also
been influenced by an increase in the availability of outpatient psychiatric services. By the mid2000s, the prevalence of outpatient office visits for BD had increased significantly in the U.S.,
with the majority of these youth and adults receiving pharmacological interventions at the
outpatient level (Moreno et al., 2007). Interventions via outpatient care could have resulted in a
decreased need for repeated hospitalizations for PBD over the past decade. However, one
outpatient clinic in the U.S. identified a significant decrease in outpatient PBD diagnosis
between 2008 and 2013 (Wesemann, 2016). Additional nationwide research is needed to
determine whether there was a general trend toward increasing or decreasing outpatient service
utilization, and whether this may have impacted the rate of inpatient PBD diagnosis.
In addition to examining overall trends in diagnosis, exploratory aims of both Study 1
and 2 included evaluating whether changes in the rate of PBD diagnosis significantly varied by
demographic variables. Among youth, there was not a significant difference in the rate of PBD
diagnosis by gender at the national or state levels suggesting that diagnostic rates of PBD were
similar for boys and girls across the study period. However, in the national data, gender
significantly interacted with year and the adult age group which suggested that adult men carried
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lower odds of receiving a BD diagnosis compared to adult women across the study period.
Findings from the present study contrast with earlier analyses that did identify gender differences
in the rate of PBD diagnosis among youth specifically (Blader & Carlson, 2007; Moreno et al.,
2007). However, epidemiological findings disagree as to whether some symptoms of PBD may
be more prevalent by gender. Some results indicate no gender differences in the actual
prevalence of BD (Diflorio & Jones, 2010; Wozniak et al., 2013). Others suggest that some
specific symptoms of PBD (i.e., increased energy, pressured speech, hyperactivity, grandiosity,
and people-seeking) may be more common among boys than girls (Van Meter et al., 2016),
which could contribute to differing diagnostic rates by gender in clinical practice if these
symptoms were more noticeable to clinicians.
While rates of BD diagnosis did not vary by gender among youth in our samples, other
variables such as race, insurance type, and geographic region significantly interacted with year to
predict BD diagnosis. In the U.S., previous analyses of clinical BD diagnosis have also observed
such variations in diagnosis (e.g., Blader & Carlson, 2007). In the present study, differences in
diagnostic rates by demographic variables were also observed in the DD group in both the state
and national samples. These patterns persisted despite no identified differences in prevalence by
most demographic variables in epidemiological research (Rowland & Marwaha, 2018;
Weissman et al., 1996). Rather than a true difference in prevalence, this variability in diagnosis
may be a result of disparities in access to mental health services across various demographic
groups. For example, African-American and Hispanic individuals were less likely to receive
treatment for mental health difficulties compared to white individuals between 1990 and 2003
(Kessler et al., 2005). Furthermore, Hispanic and African-American individuals appear to have a
greater likelihood of receiving clinical diagnoses of psychotic disorders compared to White
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individuals. African-American individuals may be less likely to be diagnosed with a mood
disorder compared to White individuals in clinical settings (Delphin-Rittmon et al., 2015).
Mental health disparities among adults and youth may result from a number of factors that
disproportionately affect minority groups, such as provider bias, discrepancies in access to care
(Alegria, Vallas, & Pumariega, 2010; McGuire & Miranda, 2008), norms regarding treatment
seeking behavior (Delphin-Rittmon et al., 2015), and socioeconomic status (Chow, Jaffee, &
Snowden, 2003). Therefore, it is possible that the impact of demographics on the diagnosis of
pediatric mood disorders may reflect broader trends in mental health disparities.
Limitations
While the present study provided evidence to suggest that the rate of PBD has decreased
since the mid-2000s, the current data cannot be used to identify the precise reasons for why
changes in inpatient diagnostic rates have occurred. Although there are a number of possible
causes, the precise reason for why changes in the prevalence of clinical diagnoses occur can be
difficult to ascertain. Further research is needed to determine the specific causes of changing
trends in pediatric mood disorder diagnosis. Additionally, this study utilized de-identified billing
data in which each data point represented a unique admission. Some individuals may have been
repeatedly hospitalized throughout the study period and may contribute more than one unique
admission to the data. Furthermore, the accuracy of administrative billing data for use in medical
research has been questioned (Johnson & Nelson, 2013). Administrative billing data from
medicine has sometimes indicated high agreement when compared to medical records or
laboratory reference standards. For example, a systematic review of the utility of billing data to
identify ventricular arrhythmias determined that the use of ICD-9 codes produced high positive
predictive values when compared to patient medical records (Tamariz, Harkins, & Nair, 2012).

38

Administrative definitions of diabetes have also demonstrated high sensitivity and positive
predictive values when compared to laboratory reference standards, though these values were
dependent upon which administrative definition of diabetes was used (Southern et al., 2010).
However, other findings have indicated that administrative billing databases may be prone to
significant errors, such as data being incorrectly entered by hospital staff (Khwaja, Syed, &
Cranston, 2002). Additionally, one administrative claims database of intracranial aneurysms
demonstrated low specificity, sensitivity, and positive predictive value in identifying cases when
compared to the neurosurgical departmental database (Woodworth, Baird, Garces-Ambrossi,
Tonascia, & Tamargo, 2009). Although billing data is associated with limitations, it may still
represent an effective means to obtain large samples in order to estimate trends in apparent
service utilization (Johnson & Nelson, 2013). A further limitation of the present study is that
findings from the state-level database are limited to a sample of Medicaid-insured youth. It is
therefore unknown whether inpatient diagnosis of pediatric mood disorders have followed the
same trends among privately insured youth at the state level. National data suggested that
diagnostic rates for both PBD and DD may vary by type of insurance coverage (i.e., governmentfunded vs. private insurance). Finally, only primary diagnoses were included in this study. It is
therefore possible that rates of inpatient PBD diagnosis may be higher when ancillary diagnoses
are considered to account for potential comorbidity.
While results of the present study should be interpreted in light of limitations, they may
provide valuable insight into changing trends in inpatient service utilization for BD in the U.S.
Costs associated with the clinical management of BD are high among adults (Dean, Gerner, &
Gerner, 2004; Stensland, Jacobson, & Nyhuis, 2007) and youth (Peele, Axelson, Xu, & Malley,
2004). Individuals with BD are estimated to utilize significantly more resources on average when

39

compared to individuals with other psychiatric disorders (Peele et al., 2004; Stensland et al.,
2007). Therefore, awareness of the current diagnostic trends for BD may assist inpatient
administrators and clinicians in preparing for anticipated service utilization and planning
allocation of resources. Further research is necessary to evaluate continuously changing
diagnostic rates and to determine the exact causes of changing trends in diagnosis across time.
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Table 1
Population-Adjusted Rates per 10,000 of Overall Psychiatric, BD, and DD Hospitalizations by Age and Year
Psychiatric Hospitalization

BD-related Hospitalization

DD-related Hospitalization

Year

Child

Adolescent

Adult

Child

Adolescent

Adult

Child

Adolescent

Adult

1996
1997
1998
1999
2000

15.56
16.55
21.47
20.25
17.67

69.92
71.20
79.98
82.85
91.90

90.45
89.88
87.58
88.63
93.58

1.29
1.56
2.70
1.52
3.15

5.98
6.04
8.39
11.74
17.48

8.34
8.57
9.07
10.22
13.20

5.05
3.91
5.24
5.54
4.58

20.57
21.80
28.16
25.40
24.20

19.16
20.25
19.26
19.80
18.90

2001
2002
2003
2004
2005

22.80
28.53
23.61
22.78
22.96

114.83
103.59
95.69
89.86
100.58

98.09
101.58
94.05
94.59
96.49

5.61
8.73
6.20
7.34
8.05

30.53
25.04
15.96
20.18
28.73

13.02
14.36
12.08
13.18
15.45

6.01
7.75
6.90
4.63
5.55

38.75
33.11
36.15
30.03
30.93

22.70
22.84
20.85
19.31
19.91

2006
2007
2008
2009
2010

25.15
28.56
21.94
21.88
28.16

105.43
104.06
70.90
88.42
90.84

95.45
92.72
80.53
81.86
79.07

8.78
7.18
4.76
5.01
5.50

34.57
25.91
19.63
19.13
25.37

15.72
15.17
13.93
12.43
12.13

6.58
7.66
6.58
7.37
9.95

30.68
30.59
23.02
31.55
34.87

19.55
18.49
16.71
17.11
17.20
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Table 2
Hierarchical Regression of Model Fit for Population-Adjusted Psychiatric Hospitalization Predicted by Year
Control
b [95% CI]
92.83*
[86.26, 99.39]

Linear
b [95% CI]
95.6712*
[86.93, 104.41]

Year x Age Group
b [95% CI]
86.42*
[72.99, 99.84]

Quadratic
b [95% CI]
75.63*
[66.33, 84.92]

Year2 x Age Group
b [95% CI]
67.67*
[61.78, 73.55]

-69.61*
[-76.45, -62.76]
-1.51
[-8.82, 5.81]

-69.54*
[-76.76, -62.32]
-1.59
[-9.05, 5.87]
-.39
[-1.07, .29]

-67.59*
[-81.31, -53.87]
8.78
[-5.70, 23.26]
.87
[-.66, 2.41]
-.29
[-1.86, 1.28]
-1.42
[-3.12, .28]

-67.84*
[-78.32, -57.37]
9.80
[.05, 19.54]
5.32*
[3.74, 6.89]
-.23
[-1.51, 1.06]
-1.52*
[-2.65, -.39]
-.31*
[-.39, -.22]

-51.35*
[-57.66, -45.03]
18.11*
[10.34, 25.89]
8.60*
[5.65, 11.55]
-6.99*
[-10.13, -3.85]
-4.96*
[-8.24, -1.67]
-.54*
[-.77, -.30]
.47*
[.22, .72]
.24
[-.01, .49]

R2

.77

.78

.80

.92

.92

F

734.60*

452.78*

385.00*

395.87*

594.39*

ΔR2

.01

.02

.12

.00

ΔF

281.82

67.78*

10.87*

198.52*

Predictors
Constant
Age Group
Child
Adult
Year
Year x Child
Year x Adult
Year2
Year2 x Child
Year2 x Adult

Note. 95% CI = 95% confidence interval.
* p < .05.
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Table 3
Hierarchical Regression of Model Fit for Population-Adjusted Rate of BD Predicted by Year
Control
b [95% CI]

Linear
b [95% CI]

Year x Age Group
b [95% CI]

Quadratic
b [95% CI]

Year2 x Age Group
b [95% CI]

23.52*
[19.70, 27.35]

20.37*
[16.06, 24.68]

16.4480*
[7.90, 25.00]

11.08*
[3.76, 18.40]

2.74
[-4.27, 9.76]

-17.12*
[-14.51, -6.58]
-10.54*
[-21.09, -13.16]

-17.12*
[-14.19, -6.46]
-10.33*
[-21.03, -13.21]
.38*
[.14, .61]

-11.75*
[-20.71, -2.78]
-6.01
[-14.76, 2.74]
.85
[-.06, 1.75]
-.64
[-1.60, .31]
-.52
[-1.46, .42]

-11.87*
[-19.36, -4.38]
-4.78
[-12.13, 2.57]
2.60*
[1.66, 3.54]
-.65
[-1.41, .12]
-.64
[-1.40, .12]
-.11*
[-.15, -.07]

-3.54
[-10.80, 3.71]
4.37
[-2.77, 11.51]
5.32*
[2.90, 7.74]
-3.37*
[-5.84, -.89]
-3.68*
[-6.14, -1.22]
-0.28*
[-.45, -.12]
.17*
[.01, .34]
.19*
[.03, .36]

R2

.59

.67

.69

.80

.83

F

62.90*

42.11*

27.90*

65.80*

63.07*

ΔR2

.08

.02

.11

.03

ΔF

20.79*

14.21

37.90*

2.73

Predictors
Constant
Age Group
Child
Adult
Year
Year x Child
Year x Adult
Year2
Year2 x Child
Year2 x Adult

Note. 95% CI = 95% confidence interval.
* p < .05.
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Table 4
Hierarchical Regression of Model Fit for Population-Adjusted Rate of DD Predicted by Year
Control
b [95% CI]

Linear
b [95% CI]

Year x Age Group
b [95% CI]

Quadratic
b [95% CI]

Year2 x Age Group
b [95% CI]

30.31*
[27.77, 32.85]

31.14*
[28.05, 34.24]

26.90*
[21.73, 32.08]

24.39*
[20.03, 28.74]

22.05*
[18.65, 25.45]

-23.72*
[-26.41, -21.02]
-10.73*
[-13.44, -8.03]

-23.68*
[-26.51, -20.86]
-10.78*
[-13.54, -8.02]
-.11
[-.27, .05]

-22.46*
[-27.72, -17.21]
-5.82*
[-11.22, -.42]
.46
[-.05, .96]
-.18
[-.70, .34]
-.67*
[-1.20, -.14]

-22.44*
[-27.30, -17.59]
-5.48*
[-10.05, -.91]
1.46*
[.87, 2.05]
-.17
[-.72, .39]
-.71*
[-1.20, -.23]
-.07*
[-.10, -.04]

-16.99*
[-20.51, -13.47]
-3.01
[-6.50, .49]
2.39872*
[.90, 3.90]
-2.38*
[-3.95, -.80]
-1.70636*
[-3.26, -.15]
-0.13*
[-.26, -.01]
.14966*
[.02, .28]
.06813
[-.06, .19]

R2

.79

.79

.83

.88

.89

F

279.73*

155.40*

231.35*

145.67*

222.67*

ΔR2

.00

.04

.05

.01

ΔF

124.33

75.95*

85.68*

77.00*

Predictors
Constant
Age Group
Child
Adult
Year
Year x Child
Year x Adult
Year2
Year2 x Child
Year2 x Adult

Note. 95% CI = 95% confidence interval.
* p < .05.
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Table 5
Logistic Regression Predicting Odds of BD Diagnosis by Demographic Variables
Interaction of Demographic Variables with Year and Age Group
Main Effects

Age Group

Gender

Race

Insurance Type

Geographic Region

OR [95% CI]

OR [95% CI]

OR [95% CI]

OR [95% CI]

OR [95% CI]

OR [95% CI]

.20 [.18, .22] *

.12 [.10, .15] *

.17 [.15, .19] *

.19 [.17, .21] *

.22 [.19, .26] *

.23 [.20, .26] *

1.13 [1.11, 1.15] *

1.26 [1.19, 1.34] *

1.11 [1.08, 1.14] *

1.12 [1.10, 1.15] *

1.08 [1.06, 1.11] *

1.08 [1.05, 1.11] *

.995 [.994, .996] *

.99 [.99, .99] *

.996 [.994, .998] *

.995 [.994, .997] *

.998 [.996, 1.00]

.998 [.996, .999] *

Child

1.11 [.98, 1.27]

.70 [.48, 1.02]

1.13 [.92, 1.39]

1.17 [1.01, 1.35] *

.95 [.79, 1.13]

1.12 [.98, 1.27]

Adult

.57 [.53, .62] *

.98 [.80 1.21]

.69 [.62, .77] *

.62 [.56, .68] *

.54 [.48, .61] *

.57 [.53, .62] *

Gender

.66 [.63, .70] *

.66 [.63, .70] *

.92 [.77, 1.11]

.66 [.63, .70] *

.66 [.63, .70] *

.66 [.63, .70] *

Race

.65 [.61, .69] *

.65 [.61, .69] *

.65 [.61, .69] *

.68 [.53, .86] *

.65 [.61, .69] *

.65 [.61, .69] *

Insurance Type

1.01 [.97, 1.06]

1.02 [.97, 1.07]

1.02 [.97, 1.07]

1.02 [.97, 1.07]

.78 [.64, .94] *

1.02 [.97, 1.07]

South

1.30 [1.25, 1.35] *

1.29 [1.24, 1.34] *

1.30 [1.25, 1.35] *

1.30 [1.25, 1.35] *

1.30 [1.25, 1.35] *

.84 [.75, .94] *

West

.80 [.75, .86] *

.80 [.75, .86] *

.80 [.75, .86] *

.80 [.75, .86] *

.80 [.75, .86] *

1.29 [1.06, 1.58] *

1.11 [1.05, 1.17] *

1.11 [1.06, 1.17] *

1.11 [1.05, 1.16] *

1.11 [1.05, 1.17] *

1.11 [1.05, 1.17] *

1.05 [.92, 1.20]

Predictor
Constant
Year
Year

2

Age Group

Geographic Region

Midwest
Interaction with Age
Child x Year

1.22 [1.09, 1.36] *

Adult x Year
Child x Year

2

Adult x Year2

.87 [.82, .93] *
.99 [.98, .99] *
1.01 [1.00, 1.01] *

Interaction with Gender
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Gender x Year
Gender x Year

1.04 [1.00, 1.08]
2

.997 [.994, .999] *

Gender x Child

.88 [.68, 1.15]

Gender x Adult

.64 [.54, .75] *

Interaction with Race
Race x Year

1.07 [1.01, 1.13] *

Race x Year2

.99 [.99, 1.00]

Race x Child

.75 [.56, 1.01]

Race x Adult

.65 [.54, .78] *

Interaction with Insurance Type
Insurance x Year

1.10 [1.06, 1.15] *

2

Insurance x Year

.992 [.990, .995] *

Insurance x Child

1.36 [1.05, 1.76] *

Insurance x Adult

1.10 [.94, 1.30]

Interaction with Geographic Region
South x Year

1.12 [1.09 1.16] *

West x Year

.87 [.82, .93] *

Midwest x Year

.97 [.93, 1.02]

South x Year2

.994 [.992, .996] *

2

West x Year

1.01 [1.00, 1.01] *

Midwest x Year2

1.00 [1.00, 1.01] *

2

Nagelkerke R

.025

.026

.026

.026

.026

.027

.001
.001
.001
.001
.002
ΔR2
2
2
Note. BD = Bipolar Disorder. OR = Odds Ratio. 95% CI = 95% confidence interval. ΔR = Change in Nagelkerke’s R between the main effects
model and interaction effects models.
* p < .05.
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Table 6
Logistic Regression Predicting Odds of DD Diagnosis by Demographic Variables
Interaction of Demographic Variables with Year and Age Group
Main Effects

Age Group

Gender

Race

Insurance Type

Geographic Region

OR [95% CI]

OR [95% CI]

OR [95% CI]

OR [95% CI]

OR [95% CI]

OR [95% CI]

Constant

.49 [.45, .53] *

.45 [.38, .52] *

.51 [.46, .57] *

.47 [.43, .52] *

.56 [.49, .63] *

.47 [.43, .52] *

Year

.98 [.96, .99] *

.96 [.91, 1.02]

.97 [.95, .99] *

.98 [.961, .997] *

.96 [.94, .98] *

.98 [.96, 1.01]

1.00 [1.00, 1.00] *

1.00 [.999 1.01]

1.00 [.999, 1.002]

1.00 [1.00, 1.00]

1.003 [1.001, 1.004] *

1.00 [.999, 1.002]

Child

.89 [.79, 1.01]

1.05 [.81, 1.37]

.89 [.74, 1.07]

.83 [.73, .96] *

.90 [.76, 1.07]

.89 [.79, 1.01]

Adult

.66 [.62, .71] *

.72 [.61, .85] *

.67 [.61, .74] *

.83 [.73, .96] *

.60 [.53, .67] *

.67 [.62, .71] *

Gender

.59 [.57, .61] *

.59 [.56, .61] *

.51 [.44, .60] *

.59 [.57, .61] *

.59 [.56, .61] *

.59 [.57, .61] *

Race

.71 [.68, .75] *

.71 [.67, .75] *

.71 [.68, .75] *

.83 [.68, 1.01]

.71 [.67, .75] *

.71 [.68, .75] *

1.39 [1.33, 1.44] *

1.39 [1.34, 1.45] *

1.39 [1.33, 1.44] *

1.39 [1.34, 1.45] *

1.10 [.93, 1.29]

1.39 [1.33, 1.45] *

South

1.23 [1.19, 1.27] *

1.23 [1.20, 1.28] *

1.23 [1.19, 1.27] *

1.23 [1.19, 1.27] *

1.23 [1.19, 1.27] *

1.24 [1.14, 1.35] *

West

.67 [.63, .71] *

.67 [.63, .71] *

.67 [.63, .71] *

.67 [.63, .71] *

.67 [.63, .71] *

.60 [.51, .70] *

1.36 [1.31, 1.42] *

1.36 [1.30, 1.42] *

1.37 [1.31, 1.43] *

1.37 [1.31, 1.43] *

1.36 [1.30, 1.42] *

1.37 [1.23, 1.52] *

Predictor

Year

2

Age Group

Insurance Type
Geographic Region

Midwest
Interaction with Age
Child x Year

.91 [.83, 1.01]

Adult x Year
Child x Year

2

Adult x Year2

1.02 [.96, 1.08]
1.01 [1.00, 1.01]
1.00 [.99, 1.00]

Interaction with Gender
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Gender x Year
Gender x Year

1.01 [.98, 1.05]
2

1.00 [.999, 1.003]

Gender x Child

.99 [.78, 1.27]

Gender x Adult

.98 [.85, 1.13]

Interaction with Race
Race x Year

.99 [.95, 1.04]

Race x Year2

1.00 [.998, 1.005]

Race x Child

1.26 [.96, 1.65]

Race x Adult

.78 [.66, .93] *

Interaction with Insurance Type
Insurance x Year

1.05 [1.01, 1.08] *

2

Insurance x Year

.996 [.994, .999] *

Insurance x Child

.93 [.73, 1.19]

Insurance x Adult

1.20 [1.04, 1.39] *

Interaction with Geographic Region
South x Year

1.00 [.97, 1.03]

West x Year

1.04 [.99, 1.09]

Midwest x Year

.99 [.95, 1.02]

South x Year2

1.00 [.998, 1.002]

2

West x Year

1.00 [.994, 1.001]

Midwest x Year2

1.00 [.999, 1.004]

2

Nagelkerke R

.033

.033

.033

.033

.033

.033

ΔR2
Note. DD = Depressive Disorders. OR = Odds Ratio. 95% CI = 95% confidence interval. ΔR2 = Change in Nagelkerke’s R2 between the main
effects model and interaction effects models.
* p < .05.
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Table 7
Nevada Hospital Admissions Counts and Sample Characteristics

Total Inpatient
Admissions
Gender
Men
n (%)
Women
n (%)
Diagnosis
PBD
n (%)
DD
n (%)

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

3,140

2,551

2,256

2,302

3,356

4,659

4,784

4,865

5,871

6,596

7,728

1,686
(54)

1,349
(53)

1,617
(72)

1,276
(55)

1,730
(52)

2,513
(54)

2,423
(51)

2,440
(50)

2,763
(47)

3,216
(49)

3,294
(43)

1,454
(46)

1,202
(47)

639
(28)

1,026
(45)

1,626
(49)

2,146
(46)

2,361
(49)

2,425
(50)

3,108
(53)

3,380
(51)

4,434
(57)

650
(21)
892
(28)

493
(19)
690
(27)

447
(20)
473
(21)

375
(16)
491
(21)

487
(15)
790
(24)

620
(13)
1,091
(23)

451
(9)
1,304
(27)

403
(8)
1,377
(28)

439
(7)
1,629
(28)

509
(8)
2,181
(33)

856
(11)
3,316
(43)
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Table 8
Hierarchical Regression Analysis of Model Fit for PBD Diagnosis Predicted by Hospital and Year
Control Model
b [95% CI]

Linear Model
b [95% CI]

Quadratic Model
b [95% CI]

Cubic Model
b [95% CI]

130.97*
[109.91, 152.02]

221.62*
[175.09, 268.15]

252.66*
[181.15, 324.17]

232.09*
[150.00, 314.18]

-25.81*
[-49.46, -2.16]
54.11
[-7.33, 115.54]
-16.23
[-55.09, 22.62]
3.48
[-27.02, 33.99]

-39.39*
[-68.95, -9.82]
40.53
[-1.23, 82.29]
-17.82
[-38.18, 2.54]
7.25
[-24.96, 39.47]
-15.42*
[-22.55, -8.29]

-40.34*
[-70.05, -10.63]
39.57*
[1.32, 77.82]
-17.33
[-40.13, 5.48]
6.70
[-20.86, 34.26]
-34.16*
[-59.69, -8.62]
1.82
[-.31, 3.95]

R2

.17

.52

.57

-43.66*
[-73.76, -13.56]
36.25
[-.01, 72.52]
-17.41
[-39.14, 4.31]
9.80
[-17.63, 37.24]
7.46
[-52.23, 67.16]
-9.07
[-21.86, 3.71]
.72
[-.07, 1.50]
.62

F

1.86

5.43*

5.50*

7.86*

ΔR2

.35

.05

.05

ΔF

3.57*

.07

2.36

Predictors
Constant
Hospital
1
2
3
4
Year
Year2
Year3

Note. 95% CI = 95% confidence interval.
* p < .05.
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Table 9

Hierarchical Regression Analysis of PBD Diagnosis Predicted by Hospital, Year, Gender, and Year x Gender Interaction
Main Effects of Year and
Gender
b [95% CI]
115.52*
[89.17, 141.87]

Control Model
b [95% CI]

Year
b [95% CI]

66.36*
[57.64, 75.09]

114.72*
[92.86, 136.57]

-13.79*
[-23.57, -4.00]
30.58*
[3.07, 58.08]
-9.00
[-23.84, 5.85]
.86
[-12.44, 14.16]

-21.23*
[-33.42, -9.03]
24.31*
[3.63, 44.98]
-10.07*
[-19.64, -.51]
2.63
[-11.12, 16.37]
-8.18*
[-11.31, -5.06]

-21.22*
[-33.47, -8.97]
24.28*
[3.67, 44.89]
-10.06*
[-19.69, -.44]
2.63
[-11.32, 16.59]
-8.18*
[-11.31, -5.05]
-1.67
[-16.83, 13.50]

-21.09*
[-33.17, -9.01]
23.95*
[3.99, 43.90]
-9.97
[-20.24, .30]
2.72
[-11.13, 16.56]
-10.69*
[-15.83, -5.54]
-30.85
[-73.25, 11.55]
5.09
[-.90, 11.08]

R2

.14

.41

.41

.44

F

2.57*

6.84*

7.47*

6.30*

ΔR2

.27

.00

.03

ΔF

4.27*

.63

1.17

Predictors
Constant

Year x Gender Interaction
b [95% CI]
129.79*
[92.03, 167.55]

Hospital
1
2
3
4
Year
Gender
Year * Gender

Note. 95% CI = 95% confidence interval.
* p < .05.
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Table 10
Hierarchical Regression Analysis of Model Fit for DD Diagnosis Predicted by Hospital and Year
Control Model
b [95% CI]

Linear Model
b [95% CI]

Quadratic Model
b [95% CI]

Cubic Model
b [95% CI]

313.41*
[283.31, 343.52]

225.42*
[166.02, 284.82]

306.34*
[243.00, 369.69]

300.17*
[228.57, 371.77]

-112.18*
[-147.23, -77.14]
18.43
[-30.79, 67.65]
34.00
[-42.70, 110.70]
-69.24
[-145.37, 6.89]

-99.01*
[-140.55, -57.46]
31.61
[-13.97, 77.19]
35.54
[-23.59, 94.66]
-72.90*
[-131.53, -14.27]
14.96*
[4.74, 25.18]

-101.50*
[-146.43, -56.57]
29.12
[-6.63, 64.86]
36.82
[-12.56, 86.20]
-74.33*
[-118.49, -30.18]
-33.90*
[-59.84, -7.95]
4.74*
[2.10, 7.38]

R2

.44

.57

.70

-102.49*
[-148.94, -56.04]
28.12
[-8.35, 64.59]
36.79
[-13.13, 86.72]
-73.40*
[-117.52, -29.29]
-21.41
[-85.37, 42.55]
1.47
[-13.97, 16.91]
.21
[-0.81, 1.24]
.70

F

20.34*

13.37*

20.52*

17.33*

ΔR2

.13

.13

.00

ΔF

6.97*

7.15*

3.19

Predictors
Constant
Hospital
1
2
3
4
Year
Year2
Year3

Note. 95% CI = 95% confidence interval.
* p < .05.
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Table 11
Hierarchical Regression Analysis of DD Diagnosis Predicted by Hospital, Year, Gender, and Year x Gender Interaction

Predictors
Constant

Linear
Year x Gender
Interaction
b [95% CI]
114.49*
[86.21,142.78

Quadratic
Year x Gender
Interaction
b [95% CI]
131.81*
[92.72, 170.91]

-53.69*
[-70.21, -37.18]
20.85
[-2.34, 44.04]
20.94
[-2.06, 43.95]
-39.29*
[-66.96, -11.62]
6.28*
[1.95, 10.61]
93.78*
[71.24, 116.32]

-53.64*
[-70.66, -36.62]
19.69
[-1.345, 40.74]
22.06*
[.56, 43.55]
-39.27*
[-64.03, -14.52]
-.40
[-4.40, 3.60]
16.38
[-31.62, 64.39]
13.43*
[5.36, 21.49]

.62
28.17*
.32
20.17*

.68
33.16*
.06
4.99*

-54.78*
[-73.29, -36.28]
18.56*
[.49, 36.62]
22.49*
[5.15, 39.82]
-39.92*
[-58.96, -20.88]
-10.76
[-23.70, 2.18]
59.61*
[8.75, 110.47]
-13.00
[-33.66, 7.66]
1.00
[-.09, 2.10]
2.57*
[.48, 4.66]
.76
38.32*
.08
5.16*

Control Model
b [95% CI]

Year
b [95% CI]

Main Effects of
Year and Gender
b [95% CI]

160.33*
[143.33, 177.33]

122.93*
[92.79, 153.08]

-76.01*
[45.42, 106.60]

-59.72*
[-80.18, -39.25]
13.49
[-18.75, 45.73]
23.59
[-11.02, 58.20]
-38.25*
[-75.96, -.54]

-53.79*
[-74.26, -33.31]
18.52
[-14.06, 51.10]
23.60
[-7.84, 55.03]
-39.40*
[-73.78, -5.01]
6.29*
[.60, 11.98]

.30
8.00*
.04
2.76*

Hospital
1
2
3
4
Year
Gender
Year * Gender
Year2
Year2 * Gender
R2
.26
F
10.76*
ΔR2
ΔF
Note. 95% CI = 95% confidence interval.
* p < .05.
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Appendix B: Figures
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Figure 1
Proportions of Mood Disorders Compared to All Adult Psychiatric Hospitalizations by Age
Children

Adolescents

Adults

56

Figure 2
Population-Adjusted Rate of Psychiatric Hospitalization by Age between 1996 and 2010
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Figure 3
Population-Adjusted Rate of BD-related Hospitalization by Age between 1996 and 2010
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Figure 4
Population-Adjusted Rate of DD-related Hospitalization by Age between 1996 and 2010
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Figure 5
Interaction between Gender and Age Group Predicting Odds of BD Diagnosis between 1996 and 2010

60

Figure 6
Interaction between Race and Age Group Predicting Odds of BD Diagnosis between 1996 and 2010
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Figure 7
Interaction between Insurance Type and Age Group Predicting Odds of BD Diagnosis between 1996 and 2010
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Figure 8
Interaction between Geographic Region and Year Predicting Odds of BD Diagnosis between 1996 and 2010
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Figure 9
Interaction between Race and Age Group Predicting Odds of DD Diagnosis between 1996 and 2010
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Figure 10
Interaction between Insurance Type and Age Group Predicting Odds of DD Diagnosis between 1996 and 2010
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Figure 11
Diagnostic Rate of PBD per 1,000 Admissions between 2005 and 2015 by Hospital

66

Figure 12
Interaction between Gender and Quadratic Effect of Year on the Rate of DD Diagnosis per 1,000 Admissions between 2005 and 2015
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